We compared the TMB level, NAL, MSI score, and DDR gene mutations between tumors carrying SMO mutations and those that are SMO wild type in the TCGA pan-cancer cohort to investigate the underlying mechanism linking SMO mutation to ICI response. This evidence concerns the gene SMO and cancer.